| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Feng Zhang | |
| Feng Cheng | |||
| Wenjie Yang | |||
| Xuehao Wang | |||
| Shikun Yang | |||
| Jianhua Rao | |||
| P2860 | cites work | NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice | Q93174195 |
| Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization | Q33589216 | ||
| Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. | Q33609699 | ||
| KRAS and YAP1 converge to regulate EMT and tumor survival | Q33946244 | ||
| B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21 | Q34048170 | ||
| The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals | Q34077795 | ||
| CD47 signaling regulates the immunosuppressive activity of VEGF in T cells | Q34289358 | ||
| The hippo pathway in heart development, regeneration, and diseases | Q34470968 | ||
| Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway | Q34479368 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| CSF-1R inhibition alters macrophage polarization and blocks glioma progression | Q34993852 | ||
| Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis | Q35086389 | ||
| Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer | Q36044341 | ||
| Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell | Q36170597 | ||
| Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy | Q36414978 | ||
| Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression | Q36447669 | ||
| Macrophage polarization in tumour progression | Q37158140 | ||
| Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. | Q37331580 | ||
| Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein | Q37618668 | ||
| Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways | Q37671165 | ||
| Role of tumour-associated macrophages in cancer-related inflammation | Q37853003 | ||
| Macrophage activation and polarization as an adaptive component of innate immunity | Q38144234 | ||
| Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. | Q38407569 | ||
| Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma | Q38829170 | ||
| Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy | Q39280710 | ||
| Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. | Q41858851 | ||
| Single tumor-initiating cells evade immune clearance by recruiting type II macrophages | Q41957741 | ||
| COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells | Q42323954 | ||
| TAMeless traitors: macrophages in cancer progression and metastasis | Q47096116 | ||
| Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma | Q47864262 | ||
| YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma. | Q48139568 | ||
| Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells. | Q48229042 | ||
| PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway | Q48524121 | ||
| YAP regulates PD-L1 expression in human NSCLC cells | Q49569691 | ||
| Regulation of the Hippo Signaling Pathway by Ubiquitin Modification | Q49797883 | ||
| A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma. | Q49823387 | ||
| Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. | Q49961097 | ||
| The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1. | Q50019997 | ||
| SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways | Q50027446 | ||
| HucMSC Exosome-Delivered 14-3-3ζ Orchestrates Self-Control of the Wnt Response via Modulation of YAP During Cutaneous Regeneration. | Q51687594 | ||
| PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy. | Q52674215 | ||
| How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations. | Q52728721 | ||
| Emerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity. | Q54398128 | ||
| Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast | Q57456357 | ||
| Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages | Q57821841 | ||
| Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer | Q58542923 | ||
| The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz | Q58544871 | ||
| Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis | Q60924208 | ||
| Tumor-secreted factors induce IL-1β maturation via the glucose-mediated synergistic axis of mTOR and NF-κB pathways in mouse macrophages | Q60933709 | ||
| GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment | Q60959769 | ||
| MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer | Q64081418 | ||
| M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling | Q64103418 | ||
| Hippo Pathway in Mammalian Adaptive Immune System. | Q64946002 | ||
| YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity. | Q64967202 | ||
| The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation | Q83560548 | ||
| The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity | Q90929391 | ||
| Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro | Q91101193 | ||
| Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology | Q91165374 | ||
| Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response | Q91225007 | ||
| Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice | Q91385568 | ||
| The Hippo Signaling Pathway in Pancreatic Cancer | Q91526795 | ||
| Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment | Q91528858 | ||
| Harnessing tumor-associated macrophages as aids for cancer immunotherapy | Q91728737 | ||
| The Emerging Role of YAP/TAZ in Tumor Immunity | Q91900528 | ||
| Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages | Q92259680 | ||
| Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells | Q92262684 | ||
| Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression | Q92376163 | ||
| The Hippo Signaling Pathway in Development and Disease | Q92452541 | ||
| YAP balances the osteogenic and adipogenic differentiation of hPDLSCs in vitro partly through the Wnt/β-catenin signaling pathway | Q92675163 | ||
| Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway | Q92986415 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 399 | |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | Annals of Translational Medicine | Q26842362 |
| P1476 | title | Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment | |
| P478 | volume | 8 |
Search more.